Table of Contents Global Diabetic Therapeutic Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Report Overview 1.1 Definition and Specification 1.2 Report Overview 1.2.1 Manufacturers Overview 1.2.2 Regions Overview 1.2.3 Type Overview 1.2.4 Application Overview 1.3 Industrial Chain 1.3.1 Diabetic Therapeutic Drugs Overall Industrial Chain 1.3.2 Upstream 1.3.3 Downstream 1.4 Industry Situation 1.4.1 Industrial Policy 1.4.2 Product Preference 1.4.3 Economic/Political Environment 1.5 SWOT Analysis 2 Product Type Market 2.1 World Product Type Market Performance and Trend 2.1.1 World Market Performance 2.1.2 Different Type of Market Performance 2.2 North America Product Type Market Performance and Trend 2.2.1 North America Market Performance 2.2.2 Different Type of Market Performance 2.3 Europe Product Type Market Performance and Trend 2.3.1 Europe Market Performance 2.3.2 Different Type of Market Performance 2.4 Asia-Pacific Product Type Market Performance and Trend 2.4.1 Asia-Pacific Market Performance 2.4.2 Different Type of Market Performance 2.5 South America Product Type Market Performance and Trend 2.5.1 South America Market Performance 2.5.2 Different Type of Market Performance 2.6 Middle East and Africa Product Type Market Performance and Trend 2.6.1 Middle East and Africa Market Performance 2.6.2 Different Type of Market Performance 3 Product Application Market 3.1 World Product Application Market Performance and Trend 3.1.1 World Market Performance 3.1.2 Different Applications of Market Trend 3.2 North America Product Application Market Performance and Trend 3.2.1 North America Market Performance 3.2.2 Different Applications of Market Trend 3.3 Europe Product Application Market Performance and Trend 3.3.1 Europe Market Performance 3.3.2 Different Applications of Market Trend 3.4 Asia-Pacific Product Application Market Performance and Trend 3.4.1 Asia-Pacific Market Performance 3.4.2 Different Applications of Market Trend 3.5 South America Product Application Market Performance and Trend 3.5.1 South America Market Performance 3.5.2 Different Applications of Market Trend 3.6 Middle East and Africa Product Application Market Performance and Trend 3.6.1 Middle East and Africa Market Performance 3.6.2 Different Applications of Market Trend 4 Manufacturers Profiles/Analysis 4.1 AstraZeneca 4.1.1 AstraZeneca Profiles 4.1.2 AstraZeneca Product Information 4.1.3 AstraZeneca Diabetic Therapeutic Drugs Business Performance 4.1.4 AstraZeneca Diabetic Therapeutic Drugs Business Development and Market Status 4.2 Eli Lilly 4.2.1 Eli Lilly Profiles 4.2.2 Eli Lilly Product Information 4.2.3 Eli Lilly Diabetic Therapeutic Drugs Business Performance 4.2.4 Eli Lilly Diabetic Therapeutic Drugs Business Development and Market Status 4.3 Merck 4.3.1 Merck Profiles 4.3.2 Merck Product Information 4.3.3 Merck Diabetic Therapeutic Drugs Business Performance 4.3.4 Merck Diabetic Therapeutic Drugs Business Development and Market Status 4.4 Novo Nordisk 4.4.1 Novo Nordisk Profiles 4.4.2 Novo Nordisk Product Information 4.4.3 Novo Nordisk Diabetic Therapeutic Drugs Business Performance 4.4.4 Novo Nordisk Diabetic Therapeutic Drugs Business Development and Market Status 4.5 Sanofi 4.5.1 Sanofi Profiles 4.5.2 Sanofi Product Information 4.5.3 Sanofi Diabetic Therapeutic Drugs Business Performance 4.5.4 Sanofi Diabetic Therapeutic Drugs Business Development and Market Status 4.6 Pfizer 4.6.1 Pfizer Profiles 4.6.2 Pfizer Product Information 4.6.3 Pfizer Diabetic Therapeutic Drugs Business Performance 4.6.4 Pfizer Diabetic Therapeutic Drugs Business Development and Market Status 4.7 Novartis 4.7.1 Novartis Profiles 4.7.2 Novartis Product Information 4.7.3 Novartis Diabetic Therapeutic Drugs Business Performance 4.7.4 Novartis Diabetic Therapeutic Drugs Business Development and Market Status 4.8 Perle Biosciences 4.8.1 Perle Biosciences Profiles 4.8.2 Perle Biosciences Product Information 4.8.3 Perle Biosciences Diabetic Therapeutic Drugs Business Performance 4.8.4 Perle Biosciences Diabetic Therapeutic Drugs Business Development and Market Status 4.9 Sun Pharma 4.9.1 Sun Pharma Profiles 4.9.2 Sun Pharma Product Information 4.9.3 Sun Pharma Diabetic Therapeutic Drugs Business Performance 4.9.4 Sun Pharma Diabetic Therapeutic Drugs Business Development and Market Status 4.10 Takeda Pharmaceuticals 4.10.1 Takeda Pharmaceuticals Profiles 4.10.2 Takeda Pharmaceuticals Product Information 4.10.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Business Performance 4.10.4 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Business Development and Market Status 4.11 F. Hoffmann-La Roche 4.12 Belrose Pharma 4.13 Merck 4.14 Novo Nordisk 4.15 Sanofi 5 Market Performance for Manufacturers 5.1 Global Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018 5.2 Global Diabetic Therapeutic Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018 5.3 Global Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 5.4 Global Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 5.5 Market Concentration 6 Regions Market Performance for Manufacturers 6.1 North America Market Performance for Manufacturers 6.1.1 North America Diabetic Therapeutic Drugs Sales (K Units) and Share of Manufacturers 2013-2018 6.1.2 North America Diabetic Therapeutic Drugs Revenue (M USD) and Share of Manufacturers 2013-2018 6.1.3 North America Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 6.1.4 North America Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 6.1.5 Market Concentration 6.2 Europe Market Performance for Manufacturers 6.2.1 Europe Diabetic Therapeutic Drugs Sales (K Units) and Share of Manufacturers 2013-2018 6.2.2 Europe Diabetic Therapeutic Drugs Revenue (M USD) and Share of Manufacturers 2013-2018 6.2.3 Europe Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 6.2.4 Europe Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 6.2.5 Market Concentration 6.3 Asia-Pacific Market Performance for Manufacturers 6.3.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Share of Manufacturers 2013-2018 6.3.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue (M USD) and Share of Manufacturers 2013-2018 6.3.3 Asia-Pacific Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 6.3.4 Asia-Pacific Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 6.3.5 Market Concentration 6.4 South America Market Performance for Manufacturers 6.4.1 South America Diabetic Therapeutic Drugs Sales (K Units) and Share of Manufacturers 2013-2018 6.4.2 South America Diabetic Therapeutic Drugs Revenue (M USD) and Share of Manufacturers 2013-2018 6.4.3 South America Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 6.4.4 South America Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 6.4.5 Market Concentration 6.5 Middle East and Africa Market Performance for Manufacturers 6.5.1 Middle East and Africa Diabetic Therapeutic Drugs Sales (K Units) and Share of Manufacturers 2013-2018 6.5.2 Middle East and Africa Diabetic Therapeutic Drugs Revenue (M USD) and Share of Manufacturers 2013-2018 6.5.3 Middle East and Africa Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 6.5.4 Middle East and Africa Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 6.5.5 Market Concentration 7 World Market Performance Point 7.1 World Diabetic Therapeutic Drugs Sales (K Units) and Share by Regions and Countries 2013-2018 7.1.1 World Diabetic Therapeutic Drugs Sales (K Units) and Share by Regions 2013-2018 7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018 7.1.2.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Share by Countries 2013-2018 7.1.2.2 North America Diabetic Therapeutic Drugs Sales (K Units) and Share by Countries 2013-2018 7.1.2.3 Europe Diabetic Therapeutic Drugs Sales (K Units) and Share by Countries 2013-2018 7.1.2.4 South America Diabetic Therapeutic Drugs Sales (K Units) and Share by Countries 2013-2018 7.1.2.5 Middle East and Africa Diabetic Therapeutic Drugs Sales (K Units) and Share by Countries 2013-2018 7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018 7.2.1 World Revenue (M USD) and Share by Regions 2013-2018 7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018 7.2.2.1 Asia-Pacific Diabetic Therapeutic Drugs Revenue (M USD) and Share by Countries 2013-2018 7.2.2.2 North America Diabetic Therapeutic Drugs Revenue (M USD) and Share by Countries 2013-2018 7.2.2.3 Europe Diabetic Therapeutic Drugs Revenue (M USD) and Share by Countries 2013-2018 7.2.2.4 South America Diabetic Therapeutic Drugs Revenue (M USD) and Share by Countries 2013-2018 7.2.2.5 Middle East and Africa Diabetic Therapeutic Drugs Revenue (M USD) and Share by Countries 2013-2018 7.3 World Price (USD/Unit) by Regions and Countries 2013-2018 7.3.1 World Price (USD/Unit) by Regions 2013-2018 7.3.2 Regional Price (USD/Unit) by Countries 2013-2018 7.3.2.1 Asia-Pacific Diabetic Therapeutic Drugs Price (USD/Unit) by Countries 2013-2018 7.3.2.2 North America Diabetic Therapeutic Drugs Price (USD/Unit) by Countries 2013-2018 7.3.2.3 Europe Diabetic Therapeutic Drugs Price (USD/Unit) by Countries 2013-2018 7.3.2.4 South America Diabetic Therapeutic Drugs Price (USD/Unit) by Countries 2013-2018 7.3.2.5 Middle East and Africa Diabetic Therapeutic Drugs Price (USD/Unit) by Countries 2013-2018 7.4 World Gross Margin by Regions and Countries 2013-2018 7.4.1 World Gross Margin by Regions 2013-2018 7.4.2 Regional Gross Margin and Share by Countries 2013-2018 7.4.2.1 Asia-Pacific Diabetic Therapeutic Drugs Gross Margin and Share by Countries 2013-2018 7.4.2.2 North America Diabetic Therapeutic Drugs Gross Margin and Share by Countries 2013-2018 7.4.2.3 Europe Diabetic Therapeutic Drugs Gross Margin and Share by Countries 2013-2018 7.4.2.4 South America Diabetic Therapeutic Drugs Gross Margin and Share by Countries 2013-2018 7.4.2.5 Middle East and Africa Diabetic Therapeutic Drugs Gross Margin and Share by Countries 2013-2018 8 Development Trend for Regions and Countries (Sales Point) 8.1 World Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3 North America Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4 Europe Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5 South America Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6 Middle East and Africa Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 9 Upstream Source, Technology and Cost 9.1 Upstream Source 9.2 Technology 9.3 Cost 10 Channel Analysis 10.1 Market Channel 10.2 Distributors 11 Consumer Analysis 11.1 Type 1 Diabetes Industry 11.2 Type 2 Diabetes Industry 11.3 Gestational Diabetes Industry 12 Market Forecast 2019-2024 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024 12.1.1 Global Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024 12.1.2 Global Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate 2019-2024 12.1.3 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.4 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.5 Europe Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.6 South America Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.7 Middle East and Africa Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024 12.2.1 Overall Market Performance 12.2.2 Insulin Therapies Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.2.3 Non-Insulin Therapies Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.3 Sales by Application 2019-2024 12.3.1 Overall Market Performance 12.3.2 Type 1 Diabetes Sales and and Growth Rate 2019-2024 12.3.3 Type 2 Diabetes Sales and and Growth Rate 2019-2024 12.3.4 Gestational Diabetes Sales and and Growth Rate 2019-2024 12.4 Price (USD/Unit) and Gross Profit 12.4.1 Global Diabetic Therapeutic Drugs Price (USD/Unit) Trend 2019-2024 12.4.2 Global Diabetic Therapeutic Drugs Gross Profit Trend 2019-2024 13 Conclusion

List of Tables and Figures Figure Product Picture of Diabetic Therapeutic Drugs Table Product Specifications of Diabetic Therapeutic Drugs Table Manufacturers List in the Report Table Manufacturers Market Share 2013-2018 Table Regions Overview in the Report Table Product Type and Standard Table Type Overview Table Product Application and Standard Table Application Overview in the Report Figure Industry Chain Structure of Diabetic Therapeutic Drugs Table Industry News List of Diabetic Therapeutic Drugs Figure New Project SWOT Analysis of Diabetic Therapeutic Drugs Table World 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Type Figure World Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2013 Figure World Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2018 Table World 2013-2018 Diabetic Therapeutic DrugsRevenue (M USD) by Type Figure World Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2013 Figure World Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2018 Table World Insulin Therapies Sales (K Units) and Growth Rate Figure World Insulin Therapies Sales (K Units) and Growth Rate Table World Insulin Therapies Revenue (M USD) and Growth Rate Figure World Insulin Therapies Revenue (M USD) and Growth Rate Table World Non-Insulin Therapies Sales (K Units) and Growth Rate Figure World Non-Insulin Therapies Sales (K Units) and Growth Rate Table World Non-Insulin Therapies Revenue (M USD) and Growth Rate Figure World Non-Insulin Therapies Revenue (M USD) and Growth Rate Table North America 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Type Figure North America Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2013 Figure North America Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2018 Table North America 2013-2018 Diabetic Therapeutic DrugsRevenue (M USD) by Type Figure North America Diabetic Therapeutic Drugs Revenue Market Share (%) by Type in 2013 Figure North America Diabetic Therapeutic Drugs Revenue Market Share (%) by Type in 2018 Table North America Insulin Therapies Sales (K Units) and Growth Rate Figure North America Insulin Therapies Sales (K Units) and Growth Rate Table North America Insulin Therapies Revenue (M USD) and Growth Rate Figure North America Insulin Therapies Revenue (M USD) and Growth Rate Table North America Non-Insulin Therapies Sales (K Units) and Growth Rate Figure North America Non-Insulin Therapies Sales (K Units) and Growth Rate Table North America Non-Insulin Therapies Revenue (M USD) and Growth Rate Figure North America Non-Insulin Therapies Revenue (M USD) and Growth Rate Table Europe 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Type Figure Europe Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2013 Figure Europe Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2018 Table Europe 2013-2018 Diabetic Therapeutic DrugsRevenue (M USD) by Type Figure Europe Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2013 Figure Europe Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2018 Table Europe Insulin Therapies Sales (K Units) and Growth Rate Figure Europe Insulin Therapies Sales (K Units) and Growth Rate Table Europe Insulin Therapies Revenue (M USD) and Growth Rate Figure Europe Insulin Therapies Revenue (M USD) and Growth Rate Table Europe Non-Insulin Therapies Sales (K Units) and Growth Rate Figure Europe Non-Insulin Therapies Sales (K Units) and Growth Rate Table Europe Non-Insulin Therapies Revenue (M USD) and Growth Rate Figure Europe Non-Insulin Therapies Revenue (M USD) and Growth Rate Table Asia-Pacific 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Type Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2013 Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2018 Table Asia-Pacific 2013-2018 Diabetic Therapeutic DrugsRevenue (M USD) by Type Figure Asia-Pacific Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2013 Figure Asia-Pacific Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2018 Table Asia-Pacific Insulin Therapies Sales (K Units) and Growth Rate Figure Asia-Pacific Insulin Therapies Sales (K Units) and Growth Rate Table Asia-Pacific Insulin Therapies Revenue (M USD) and Growth Rate Figure Asia-Pacific Insulin Therapies Revenue (M USD) and Growth Rate Table Asia-Pacific Non-Insulin Therapies Sales (K Units) and Growth Rate Figure Asia-Pacific Non-Insulin Therapies Sales (K Units) and Growth Rate Table Asia-Pacific Non-Insulin Therapies Revenue (M USD) and Growth Rate Figure Asia-Pacific Non-Insulin Therapies Revenue (M USD) and Growth Rate Table South America 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Type Figure South America Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2013 Figure South America Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2018 Table South America 2013-2018 Diabetic Therapeutic DrugsRevenue (M USD) by Type Figure South America Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2013 Figure South America Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2018 Table South America Insulin Therapies Sales (K Units) and Growth Rate Figure South America Insulin Therapies Sales (K Units) and Growth Rate Table South America Insulin Therapies Revenue (M USD) and Growth Rate Figure South America Insulin Therapies Revenue (M USD) and Growth Rate Table South America Non-Insulin Therapies Sales (K Units) and Growth Rate Figure South America Non-Insulin Therapies Sales (K Units) and Growth Rate Table South America Non-Insulin Therapies Revenue (M USD) and Growth Rate Figure South America Non-Insulin Therapies Revenue (M USD) and Growth Rate Table Middle East and Africa 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Type Figure Middle East and Africa Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2013 Figure Middle East and Africa Diabetic Therapeutic Drugs Sales Market Share (%) by Type in 2018 Table Middle East and Africa 2013-2018 Diabetic Therapeutic DrugsRevenue (M USD) by Type Figure Middle East and Africa Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2013 Figure Middle East and Africa Diabetic Therapeutic DrugsRevenue Market Share (%) by Type in 2018 Table Middle East and Africa Insulin Therapies Sales (K Units) and Growth Rate Figure Middle East and Africa Insulin Therapies Sales (K Units) and Growth Rate Table Middle East and Africa Insulin Therapies Revenue (M USD) and Growth Rate Figure Middle East and Africa Insulin Therapies Revenue (M USD) and Growth Rate Table Middle East and Africa Non-Insulin Therapies Sales (K Units) and Growth Rate Figure Middle East and Africa Non-Insulin Therapies Sales (K Units) and Growth Rate Table Middle East and Africa Non-Insulin Therapies Revenue (M USD) and Growth Rate Figure Middle East and Africa Non-Insulin Therapies Revenue (M USD) and Growth Rate Table World 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Application Figure World Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2013 Figure World Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2018 Table World Type 1 Diabetes Sales (K Units) and Growth Rate Figure World Type 1 Diabetes Sales (K Units) and Growth Rate Table World Type 2 Diabetes Sales (K Units) and Growth Rate Figure World Type 2 Diabetes Sales (K Units) and Growth Rate Table World Gestational Diabetes Sales (K Units) and Growth Rate Figure World Gestational Diabetes Sales (K Units) and Growth Rate Table North America 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Application Figure North America Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2013 Figure North America Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2018 Table North America Type 1 Diabetes Sales (K Units) and Growth Rate Figure North America Type 1 Diabetes Sales (K Units) and Growth Rate Table North America Type 2 Diabetes Sales (K Units) and Growth Rate Figure North America Type 2 Diabetes Sales (K Units) and Growth Rate Table North America Gestational Diabetes Sales (K Units) and Growth Rate Figure North America Gestational Diabetes Sales (K Units) and Growth Rate Table Europe 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Application Figure Europe Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2013 Figure Europe Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2018 Table Europe Type 1 Diabetes Sales (K Units) and Growth Rate Figure Europe Type 1 Diabetes Sales (K Units) and Growth Rate Table Europe Type 2 Diabetes Sales (K Units) and Growth Rate Figure Europe Type 2 Diabetes Sales (K Units) and Growth Rate Table Europe Gestational Diabetes Sales (K Units) and Growth Rate Figure Europe Gestational Diabetes Sales (K Units) and Growth Rate Table Asia-Pacific 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Application Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2013 Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2018 Table Asia-Pacific Type 1 Diabetes Sales (K Units) and Growth Rate Figure Asia-Pacific Type 1 Diabetes Sales (K Units) and Growth Rate Table Asia-Pacific Type 2 Diabetes Sales (K Units) and Growth Rate Figure Asia-Pacific Type 2 Diabetes Sales (K Units) and Growth Rate Table Asia-Pacific Gestational Diabetes Sales (K Units) and Growth Rate Figure Asia-Pacific Gestational Diabetes Sales (K Units) and Growth Rate Table South America 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Application Figure South America Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2013 Figure South America Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2018 Table South America Type 1 Diabetes Sales (K Units) and Growth Rate Figure South America Type 1 Diabetes Sales (K Units) and Growth Rate Table South America Type 2 Diabetes Sales (K Units) and Growth Rate Figure South America Type 2 Diabetes Sales (K Units) and Growth Rate Table South America Gestational Diabetes Sales (K Units) and Growth Rate Figure South America Gestational Diabetes Sales (K Units) and Growth Rate Table Middle East and Africa 2013-2018 Diabetic Therapeutic Drugs Sales (K Units) by Application Figure Middle East and Africa Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2013 Figure Middle East and Africa Diabetic Therapeutic Drugs Sales Market Share (%) by Application in 2018 Table Middle East and Africa Type 1 Diabetes Sales (K Units) and Growth Rate Figure Middle East and Africa Type 1 Diabetes Sales (K Units) and Growth Rate Table Middle East and Africa Type 2 Diabetes Sales (K Units) and Growth Rate Figure Middle East and Africa Type 2 Diabetes Sales (K Units) and Growth Rate Table Middle East and Africa Gestational Diabetes Sales (K Units) and Growth Rate Figure Middle East and Africa Gestational Diabetes Sales (K Units) and Growth Rate Table AstraZeneca Profiles Table AstraZeneca Product Information Table AstraZeneca Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table AstraZeneca Diabetic Therapeutic Drugs Sales Change 2013-2018 Table AstraZeneca Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Eli Lilly Profiles Table Eli Lilly Product Information Table Eli Lilly Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Eli Lilly Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Eli Lilly Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Merck Profiles Table Merck Product Information Table Merck Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Merck Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Merck Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Novo Nordisk Profiles Table Novo Nordisk Product Information Table Novo Nordisk Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Novo Nordisk Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Novo Nordisk Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Sanofi Profiles Table Sanofi Product Information Table Sanofi Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Sanofi Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Sanofi Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Pfizer Profiles Table Pfizer Product Information Table Pfizer Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Pfizer Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Pfizer Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Novartis Profiles Table Novartis Product Information Table Novartis Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Novartis Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Novartis Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Perle Biosciences Profiles Table Perle Biosciences Product Information Table Perle Biosciences Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Perle Biosciences Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Perle Biosciences Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Sun Pharma Profiles Table Sun Pharma Product Information Table Sun Pharma Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Sun Pharma Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Sun Pharma Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table Takeda Pharmaceuticals Profiles Table Takeda Pharmaceuticals Product Information Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales Change 2013-2018 Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Market Status Change 2013-2018 Table World Diabetic Therapeutic Drugs Sales (K Units) of Manufacturers 2013-2018 Table World Diabetic Therapeutic Drugs Sales Share of Manufacturers 2013-2018 Figure World Diabetic Therapeutic Drugs Sales Share in 2013 Figure World Diabetic Therapeutic Drugs Sales Share in 2018 Table World Revenue (M USD) of Manufacturers 2013-2018 Table World Revenue Share of Manufacturers 2013-2018 Figure World Revenue Share in 2013 Figure World Revenue Share in 2018 Table World Price (USD/Unit) of Manufacturers 2013-2018 Figure World Price (USD/Unit) of Manufacturers in 2013 Figure World Price (USD/Unit) of Manufacturers in 2018 Table World Gross Margin of Manufacturers 2013-2018 Figure World Gross Margin of Manufacturers in 2013 Figure World Gross Margin in 2018 Figure World Market Concentration 2013-2018 Table Top 3 Sales Share 2013-2018 Table Top 5 Sales Share 2013-2018 Table Top 8 Sales Share 2013-2018 Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) of Manufacturers 2013-2018 Table Asia-Pacific Diabetic Therapeutic Drugs Sales Share of Manufacturers 2013-2018 Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Share in 2013 Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Share in 2018 Table Asia-Pacific Diabetic Therapeutic Drugs Revenue (M USD) of Manufacturers 2013-2018 Table Asia-Pacific Diabetic Therapeutic Drugs Revenue Share of Manufacturers 2013-2018 Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue Share in 2013 Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue Share in 2018 Table Asia-Pacific Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 Figure Asia-Pacific Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers in 2013 Figure Asia-Pacific Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers in 2018 Table Asia-Pacific Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 Figure Asia-Pacific Diabetic Therapeutic Drugs Gross Margin of Manufacturers in 2013 Figure Asia-Pacific Diabetic Therapeutic Drugs Gross Margin in 2018 Figure Asia-Pacific Market Concentration 2013-2018 Table Top 3 Sales Share 2013-2018 Table Top 5 Sales Share 2013-2018 Table Top 8 Sales Share 2013-2018 Table North America Diabetic Therapeutic Drugs Sales (K Units) of Manufacturers 2013-2018 Table North America Diabetic Therapeutic Drugs Sales Share of Manufacturers 2013-2018 Figure North America Diabetic Therapeutic Drugs Sales Share in 2013 Figure North America Diabetic Therapeutic Drugs Sales Share in 2018 Table North America Diabetic Therapeutic Drugs Revenue (M USD) of Manufacturers 2013-2018 Table North America Diabetic Therapeutic Drugs Revenue Share of Manufacturers 2013-2018 Figure North America Diabetic Therapeutic Drugs Revenue Share in 2013 Figure North America Diabetic Therapeutic Drugs Revenue Share in 2018 Table North America Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018 Figure North America Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers in 2013 Figure North America Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers in 2018 Table North America Diabetic Therapeutic Drugs Gross Margin of Manufacturers 2013-2018 Figure North America Diabetic Therapeutic Drugs Gross Margin of Manufacturers in 2013 Figure North America Diabetic Therapeutic Drugs Gross Margin in 2018 Figure North America Market Concentration 2013-2018 Table Top 3 Sales Share 2013-2018 Table Top 5 Sales Share 2013-2018 Table Top 8 Sales Share 2013-2018 Table Europe Diabetic Therapeutic Drugs Sales (K Units) of Manufacturers 2013-2018 Table Europe Diabetic Therapeutic Drugs Sales Share of Manufacturers 2013-2018 Figure Europe Diabetic Therapeutic Drugs Sales Share in 2013 Figure Europe Diabetic Therapeutic Drugs Sales Share in 2018 Table Europe Diabetic Therapeutic Drugs Revenue (M USD) of Manufacturers 2013-2018 Table Europe Diabetic Therapeutic Drugs Revenue Share of Manufacturers 2013-2018 Figure Europe Diabetic Therapeutic Drugs Revenue Share in 2013 Figure Europe Diabetic Therapeutic Drugs Revenue Share in 2018 Table Europe Diabetic Therapeutic Drugs Price (USD/Unit) of Manufacturers 2013-2018

AstraZeneca Eli Lilly Merck Novo Nordisk Sanofi Pfizer Novartis Perle Biosciences Sun Pharma Takeda Pharmaceuticals F. Hoffmann-La Roche Belrose Pharma Mitsubishi Tanabe Pharma Dong-A ST Eisai